Affiliation:
1. Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University
Abstract
The review describes the mechanism of T2 inflammation and its relationship with chronic polypous rhinosinusitis. The authors conducted a search and systematization of data on the treatment of polypous rhinosinusitis using monoclonal antibodies that act on various biomarkers, and touched upon the problem of local IgE inflammation in the nasal mucosa.
Publisher
The National Academy of Pediatric Science and Innovation
Reference25 articles.
1. Piskunov G.Z., Moiseeva Yu.P. Polypous rhinosinusitis, 2nd ed., add. M.: MEDpressinform 2021; 136 s. (in Russ.)
2. Ryazancev S.V. Clinical recommendations “Polypous rhinosinusitis”. Moskva—Sankt-Peterburg. 2014; 20 s. (in Russ.)
3. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 2020; 58(Suppl S29): 1–464. DOI: 10.4193/Rhin20.600
4. Dunican E.M., Fahy J.V. The role of type 2 inflammation in the pathogenesis of asthma exacerbations. Ann Am ThoracSoc 2015; 12 (Suppl 2): 144–149. DOI: 10.1513/AnnalsATS.201506-377AW
5. Gevaert P., Wong K., Millette L.A., Carr T.F. The Role of IgE in Upper and Lower Airway Disease: More Than Just Allergy! Clinic Rev Allerg Immunol 2022; 62: 200–215. DOI: 10.1007/S12016–021–08901–1